MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / Nano4Imaging
Medical device company profile

Nano4Imaging

German medical device company developing MR-conditional guidewires and MRI-based interventional navigation technology.

Medical Device Manufacturer and DeveloperDiagnostics & ImagingDiagnostic Imaging
Headquarters🇩🇩Düsseldorf, North Rhine-Westphalia, Germany
Founded2011
Commercial statusCommercially availableCommercial · Selected U.S. guidewire clearances verified
Employees11–50LinkedIn company-size range
Estimated revenueNot confirmed
Disclosed funding≈ US$2.8 million€2,482,709 EU contribution to TRACKR · grant agreement signed March 2023
Official websitenano4imaging.com ↗

Company overview

Nano4Imaging is a Düsseldorf, Germany medical device company founded in 2011 and led by co-founder and CEO Rudolf Schulze Vohren. Its work combines guidewire design, imaging markers and navigation software for procedures performed under MRI guidance.

The EmeryGlide family comprises metal-free guidewires intended to introduce and position diagnostic or interventional devices. The company labels the guidewires MR Conditional: their use depends on specified MRI conditions rather than an unrestricted claim of MRI safety.

Nano4Imaging is also developing and presenting trackr.ai navigation software for image-guided interventions. Its EU-funded TRACKR project supported that platform’s development. The guidewire clearances and the software’s regulatory position must be considered separately.

[1][2][3][4][5][9]

Leadership

6 people
Rudolf Schulze VohrenCo-founder & Chief Executive Officer [1]
Cansu AhlemeyerChief Financial Officer [1]
Lucien de MosChief Operating Officer [1]
Samuel Mueller, Dr.-Ing.Chief Technology Officer [1]
Natalie TheisenHead of Regulatory & Quality [1]
Paul Borm, PhDCo-founder & Scientific Advisory Board Chair [1]

Products & regulatory status How does MedTechIndex get this information?

Summary

FDA records identify three guidewire clearances: K160594, K173423 and K253262. These records concern MR Wire and EmeryGlide configurations; MR Conditional labeling requires compliance with the relevant scanning conditions. [1][6][7][8]

The trackr.ai software is a distinct part of the company’s portfolio. The guidewire clearances do not authorize every software function, catheter or clinical application described in the broader TRACKR development programme. [1][6][7][8]

Regulatory snapshot How to read this snapshot

U.S. FDA
3+
510(k) clearances
—
De Novo grants
—
PMA approvals
—
Recall events

Latest recorded source review: 2026-11-05.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Nano4Imaging EmeryGlide / MR Wire guidewire family — official manufacturer product image
Image: Nano4Imaging
MR-conditional vascular guidewire

EmeryGlide / MR Wire guidewire family ↗

Metal-free guidewire family for introduction and placement of diagnostic or interventional devices under specified MR conditions. U.S. records cover earlier MR Wire configurations and a later EmeryGlide model. [1][6][7][8]

Commercial · Selected U.S. guidewire clearances verified

Commercial development

Nano4Imaging trackr.ai navigation platform — official manufacturer product image
Image: Nano4Imaging
MRI interventional navigation software

trackr.ai navigation platform ↗

Image-based navigation platform combining MRI-compatible devices with software for real-time catheter visualization and procedural guidance. The guidewire clearances do not establish a separate software clearance. [1]

Navigation platform · U.S. authorization not established

Activity & Milestones

3 events
2026-03-06 · Regulatory

EmeryGlide model receives U.S. clearance

FDA cleared the EmeryGlide model recorded under K253262. [8]

2023-03-08 · Funding

TRACKR grant agreement signed

CORDIS records an EU contribution of €2,482,709 to the TRACKR project. [3]

2016-11-22 · Regulatory

MR Wire receives U.S. clearance

FDA cleared MRWire Guide Wire under K160594. [7]

9 Cited Sources

Accessed 11/05/2026

[4] CORDIS — TRACKR development reporting ↗European Commission / CORDIS · other
[6] FDA 510(k) K173423 — MR Wire Guide Wire Straight, MR Wire Guide Wire Angled ↗U.S. Food and Drug Administration · regulator · Published 2017-11-17
[7] FDA 510(k) K160594 — MRWire Guide Wire ↗U.S. Food and Drug Administration · regulator · Published 2016-11-22
[8] FDA 510(k) K253262 — EmeryGlide™ (EG18008901) ↗U.S. Food and Drug Administration · regulator · Published 2026-03-06
[9] ECB currency conversion reference rates — 2026-11-04 ↗European Central Bank · other · Published 2026-11-04Disclosed funding originally reported as €2,482,709. Approximate USD comparison equivalent using ECB reference rates dated 2026-11-04: 1 EUR = US$1.12670000. Rounded for display.
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy